Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGAL | P20701 | 9/20 | 0.49 |
| ▸ | ITGB2 | P05107 | 8/20 | 0.49 |
| ▸ | ICAM1 | P05362 | 8/20 | 0.49 |
| ▸ | CAPN1 | P07384 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 3/20 | 0.37 |
| ▸ | RAB9A | P51151 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6500158 | 1.00 | ITGAL (0.49) | ITGALITGB2ICAM1CAPN1KDM4E | |
| SCHEMBL8298116 | 0.95 | ITGAL (0.50) | ITGALITGB2ICAM1CAPN1KDM4E | |
| SCHEMBL6503366 | 0.92 | ITGAL (0.52) | ITGALITGB2ICAM1CAPN1NPC1 | |
| SCHEMBL8297598 | 0.92 | ITGAL (0.52) | ITGALITGB2ICAM1CAPN1NPC1 | |
| SCHEMBL6533525 | 0.92 | ITGAL (0.50) | ITGALITGB2ICAM1CAPN1KDM4E | |
| SCHEMBL6503372 | 0.92 | ITGAL (0.52) | ITGALITGB2ICAM1CAPN1NPC1 | |
| SCHEMBL8296849 | 0.92 | ITGAL (0.50) | ITGALITGB2ICAM1CAPN1KDM4E | |
| SCHEMBL6533524 | 0.92 | ITGAL (0.50) | ITGALITGB2ICAM1CAPN1KDM4E | |
| SCHEMBL8297597 | 0.91 | ITGAL (0.51) | ITGALITGB2ICAM1CAPN1KDM4E | |
| SCHEMBL6502770 | 0.91 | ITGAL (0.51) | ITGALITGB2ICAM1CAPN1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005016883-A2 | ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF | ICOS CORPORATION (US) | 2005-02-24 | — | — | WO | disclosed |